Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Puma Biotech: Q2 Earnings Snapshot AP - Thu Aug 6, 4:22PM CDT

Puma Biotech: Q2 Earnings Snapshot

PBYI : 8.83 (+1.38%)
Puma Biotechnology Reports Second Quarter 2026 Financial Results Business Wire - Thu Aug 6, 3:05PM CDT

Raising 2026 Revenue and Net Income Guidance Based on Increased Demand for NERLYNX

PBYI : 8.83 (+1.38%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Wed Aug 5, 4:00PM CDT

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on August 3, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 8.83 (+1.38%)
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results Business Wire - Thu Jul 23, 3:10PM CDT

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, August 6, 2026, following the release of its second quarter 2026...

PBYI : 8.83 (+1.38%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Thu Jul 2, 4:03PM CDT

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on July 1, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 8.83 (+1.38%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Wed Jun 3, 4:00PM CDT

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 1, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 8.83 (+1.38%)
MarketBeat.com
Puma Biotechnology Q1 Earnings Call Highlights MarketBeat - Fri May 8, 2:12PM CDT

Puma Biotechnology (NASDAQ:PBYI) reported first-quarter 2026 total revenue of $44.8 million, driven primarily by NERLYNX product revenue net of $42.0 million and royalty revenue of $2.8 million, according...

PBYI : 8.83 (+1.38%)
Puma Biotech: Q1 Earnings Snapshot AP - Thu May 7, 4:37PM CDT

Puma Biotech: Q1 Earnings Snapshot

PBYI : 8.83 (+1.38%)
Puma Biotechnology Reports First Quarter 2026 Financial Results Business Wire - Thu May 7, 3:05PM CDT

Raising 2026 Revenue and Net Income Guidance Based on Increased Demand for NERLYNX

PBYI : 8.83 (+1.38%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Wed May 6, 4:15PM CDT

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on May 5, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 8.83 (+1.38%)

Barchart Exclusives

Elon Musk Said Tesla Short Sellers Would Be ‘Obliterated’ Even Bill Gates — Yet They’ve Made $9 Billion This Year Shorting the Stock Barchart - Sat Aug 15, 2:30PM CDT
Tesla short sellers have made roughly $9 billion in paper gains in 2026, two years after Elon Musk warned they’d be “obliterated” once autonomy and Optimus hit key milestones. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.